This is so awesome, not just seemingly halting disease progression but to show signs of vision improvement... meaning dormant retina cells can recover and return a degree of sight that had previously been lost.
Such a terrific signal at this early stage, would have to inspire optimism for RP11 sufferers to know how well PYC are tracking towards a robust outcome!
Exciting indeed!
Ann: Presentation of RP11 Clinical Trial Data at ARVO Conference, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.23 |
Change
0.025(2.08%) |
Mkt cap ! $699.9M | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.23 | $1.20 | $393.8K | 327.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 15248 | $1.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.23 | 22001 | 2 |
View Market Depth
| Last trade - 10.20am 24/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |